This section has resources that you may require for your formulary submissions and business cases or policy reviews. As well as product information, therapy support resources and treatment guidelines. You can download these materials to better support your decision making.

<h4>To unlock content tailored to your locality and receive emails about our products and services</h4>

Diabetes and Cardiovascular

Vaccines

Dermatology

Oncology

PAYOR

OUT-OF-TAXONOMY

Get in Touch with the Health System Solutions Team

Formulary and Service Support

The NHS is one of the world’s first healthcare systems to explicitly put sustainability in its targets which. As a committed NHS partner, we’re supporting in numerous ways. These include providing carbon reduction plans in our NHS tenders at the same time as tackling climate change and accelerating the reduction of our own environmental impact across the business.​

Sanofi launched the Repen programme in 2024. This pilot programme forms part of Sanofi’s commitment to environmental protection. The used pens are posted back for recycling, free of charge to be recycled into metal, glass and plastic furniture.&nbsp;
Read more on the Repen recycling initiative that saves thousands of tonnes of waste each year.

<h2>How is Sanofi building a sustainable environment?&nbsp;</h2>

Sanofi is working to minimise the impacts of its activities and medicines on the environment through its Planet Care environmental sustainability programme, an approach that engages everyone at Sanofi.

Let’s Be Sustainable

Collaboration with healthcare organisations and the NHS to deliver real value beyond our medicines. Explore different joint working working projects covering a range of disease areas, including diabetes, oncology, dermatology, vaccines and cardiovascular disease that deliver benefits to the patients, healthcare organisations and life sciences companies involved. Whenever possible, we publish the conclusions of our collaborative working so that others can learn from our experiences.

Sanofi undertakes collaborative working projects for the benefit of patients and/or the NHS. These projects are entirely non promotional and are not linked in any way to any of our products.

Transplant

Diabetes

Let’s be Collaborative​ and Transformative

<a href="${link:{uuid:{8e9c1745-d4cd-4c78-a226-f934d2da127e},repository:{dam},path:{/Portal/UK/Prescribing-links/MenQuadfi-PI-GB-June-2023.pdf}}}">MenQuadfiTM</a>▼ <a href="${link:{uuid:{8e9c1745-d4cd-4c78-a226-f934d2da127e},repository:{dam},path:{/Portal/UK/Prescribing-links/MenQuadfi-PI-GB-June-2023.pdf}}}">(meningococcal (group A,C,W,Y) conjugate vaccine)&nbsp;Prescribing Information</a>
MenQuadfiTM is only available in Great Britain
<h3 style="margin-bottom: 14px;">What?</h3>
Hajj is the annual Islamic pilgrimage to Makkah (Mecca) in the Kingdom of Saudi Arabia (KSA).
<ul>
 <li style="margin-bottom: 14px; margin-left: 8px;">It is attended by approximately 3 million Muslims each year</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">All adult, able-bodied Muslims are required to undertake Hajj at least once in their lifetime if they have the means to do so</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Umrah is a shorter, non-compulsory pilgrimage for Muslims, which is performed as part of the Hajj ritual, but can also be undertaken at any time.1</li>
</ul>
<h3 style="margin-bottom: 14px;">When?</h3>
Hajj occurs between the 8th and 12th day of the twelfth month of the Islamic calendar.
<ul>
 <li style="margin-bottom: 14px; margin-left: 8px;">In 2024 it is estimated to be from 14th – 19th June. </li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Umrah can be undertaken at any time of year.1</li>
</ul>
<h3 style="margin-bottom: 14px;">Preparation</h3>
Healthcare professional checklist for patients who will be attending Hajj or Umrah:
<ul style="margin-bottom:14px">
 <li style="margin-bottom:14px; margin-left:8px">Ensure they are up to date on all routine immunisations1</li>
 <li style="margin-bottom:14px; margin-left:8px">Check on their fitness level and ask about any existing medical conditions. Hajj rituals can be taxing.1</li>
 <li style="margin-bottom:14px; margin-left:8px">Remind them to practise good hand hygiene and avoid sharing drinks and eating utensils1
 <ul>
 <li style="margin-bottom:14px; margin-left:8px">Required vaccinations:1</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">COVID-19 – full course</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">MenACWY vaccine received at least 10 days prior to arrival to Hajj &amp; Umrah areas</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Polio</li>
 <li style="margin-bottom: 14px; margin-left: 8px;">Yellow Fever</li>
 </ul></li>
</ul>
See the <a href="https://travelhealthpro.org.uk/factsheet/19/hajj-and-umrah" style="color:#0563c1; text-decoration:underline">NaTHNaC Travel Health Pro</a> page for further recommended vaccines and other health risks.

<h2>Order Hajj and Umrah patient posters</h2>
Download posters on Hajj and Umrah for your patients in the language you need below or contact our Customer Service team on&nbsp;<a href="tel:+44 (0) 800854430">0800 854 430</a>&nbsp;(choose "option 1") to have them delivered to you.

<a href="${link:{uuid:{39c5ce2c-bffc-4afc-b593-f0267639021d},repository:{dam},path:{/Portal/UK/Articles/hajj/Hajj-Poster-Eng.pdf}}}">Download English</a>

<a href="${link:{uuid:{4d7b5527-8759-4931-8824-ace49016dad3},repository:{dam},path:{/Portal/UK/Articles/hajj/Hajj-Poster---Arabic.pdf}}}">Download Arabic</a>

<a href="${link:{uuid:{d809368d-3dc7-44cf-9f3f-69c36e970a0b},repository:{dam},path:{/Portal/UK/Articles/hajj/Hajj-Poster---Hindi.pdf}}}">Download Hindi</a>

<a href="${link:{uuid:{5f28a153-3e12-4562-a219-3f5d4b0b2a90},repository:{dam},path:{/Portal/UK/Articles/hajj/Hajj-Poster---Urdu.pdf}}}">Download Urdu</a>

Patients can find more information about Hajj on the&nbsp;<a href="https://www.fitfortravel.nhs.uk/home" target="_blank">NHS Fit For Travel website</a>.

Direct your patients to the&nbsp;<a href="https://www.smarter-traveller.co.uk/">Smarter Traveller website</a>&nbsp;to find tips and advice on Hajj and other health topics.

Order&nbsp;<a href="https://www.medisa.com/medisa/" target="_blank">patient materials</a>&nbsp;including an epidemiology travel map and disease leaflets

You can order Sanofi Vaccines in two ways: online at VAXISHOP or through our call centre.&nbsp;<a href="/uk/other-vaccines-topics/resources/vaccines-ways-to-order">Read more about ordering vaccines</a>.

<a href="tel:+44 (0) 800 854 430" target="_self">CALL 0800 854 430</a>

Ways to order

Prescribing Information (GB only)

TRAVEL

VACCINES

Hajj & Umrah 2024

<a href="${link:{uuid:{3c621072-b317-4715-bb3e-c63ceb933735},repository:{dam},path:{/Portal/UK/Prescribing-links/Dupixent-AD-and-PN-GB-PI.pdf}}}">Dupixent (dupilumab) Prescribing Information GB</a>

<a href="${link:{uuid:{24d957f3-a739-4a69-83e2-5be7f4b65bff},repository:{dam},path:{/Portal/UK/Prescribing-links/Dupixent-AD-and-PN-PI-IE-XI.pdf}}}">Dupixent (dupilumab) Prescribing Information NI/ROI</a>

<h2>Listen to the Hot Topics in Atopic Dermatitis podcasts</h2>
Your hosts, Emmanuel Toni and Aisling Clery, are Advanced Nurse Practitioners in Medical Dermatology, working in large NHS Foundation Trusts in London. Both are passionate about education and co-host their own podcast called ‘Dermatology UK The Podcast’, where they chat about all things skin.
Join Emmanuel and Aisling in this podcast series Hot Topics in Atopic Dermatitis, in which they discuss some of the current trends impacting the treatment landscape of patients with atopic dermatitis with UK dermatology specialists.
<a href="https://pro.campus.sanofi/uk/resources/hot-topics-in-atopic-dermatitis#long-term-disease-control">1. Long-term disease control — when to escalate or change treatment</a>
<a href="https://pro.campus.sanofi/uk/resources/hot-topics-in-atopic-dermatitis#from-systemics-to-advanced-therapy">2. Moving from systemics to advanced therapy (when to make that switch?)</a>
<a href="https://pro.campus.sanofi/uk/atopic-dermatitis/resources/hot-topics-in-atopic-dermatitis#novel-therapies">3.&nbsp;Novel Therapies — tips on how to quickly access treatment for patients</a>
<a href="https://pro.campus.sanofi/uk/atopic-dermatitis/resources/hot-topics-in-atopic-dermatitis#skin-of-colour">4.&nbsp;Skin of Colour — accuracy in assessment and diagnosis</a>

<h2>Long term disease control&nbsp;— when to escalate or change treatment</h2>

Listen to Emmanuel and Aisling talking to Dr Rick Woolf, Clinical Lead for Medical Dermatology at the St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and member of the British Association of Dermatologists National Guideline Committee on the use of biologics.
In this episode of Hot Topics in Atopic Dermatitis, they chat about long-term disease control, the role of safety in treatment decisions, patient outcome measures, and factors that influence treatment change.

<h2>Moving from systemics to advanced therapy&nbsp;— when to make that switch</h2>

Listen to Emmanuel and Aisling talking to Dr Andrew Pink, a leading Consultant Dermatologist and the Director of the Adult Clinical Trials Unit at the St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London.
In this episode of Hot Topics in Atopic Dermatitis, they chat about&nbsp;long-term disease control, impact on service provision, access to novel therapies, and patient outcome measures.

<h2>Novel therapies&nbsp;—&nbsp;tips on how to access treatment for young patients</h2>

Listen to Emmanuel and Aisling talking to Dr Tess McPherson, Lead Paediatric and Adolescent Dermatologist at Oxford University Hospitals NHS Foundation Trust, President of the British Society of Paediatric and Adolescent Dermatology, and author of ‘Young People’s Skin Conditions’.
In this episode of Hot Topics in Atopic Dermatitis they chat about factors that influence treatment choice, the role of novel therapies in the treatment landscape, and accessibility for paediatric patients.

<h2>Skin of colour&nbsp;—&nbsp;accuracy of process in assessment and diagnosis</h2>

Listen to Emmanuel and Aisling talking to Dr Marisa Taylor, Consultant Dermatologist and Biologics Lead at Epsom and St. Helier University Hospitals NHS Trust and Co-founder and Consultant Lead for The Skin of Colour Training UK.
In this episode of&nbsp;Hot Topics in Atopic Dermatitis&nbsp;they chat about treatment choice and factors that influence these decisions, patient outcome measures in different skin types, and treatment monitoring requirements.

<h2 style="text-align: center;">Discover other resources 
 &nbsp;</h2>

DUPIXENT (dupilumab) Prescribing Information GB

DUPIXENT (dupilumab) Prescribing Information NI/ROI

ATOPIC-DERMATITIS

DERMATOLOGY

Hot Topics in Atopic Dermatitis

<h2>To download PDF copies of dietician resources, please click the relevant links below:</h2>

Overview of Healthy Eating and Special Diets

OTHER-RARE-DISEASE-TOPICS

RARE-DISEASE

Dietician Resources for patients with Rare Diseases

<h2>Details</h2>
Click below to enter the website for patients in Britain who have been prescribed Nexviadyme, or their caregiver.

POMPE

NEXVIADYME 
 avalglucosidase alfa

<table border="1" cellpadding="1" cellspacing="1" style="width:100%;">
 <tbody>
 <tr>
 <td>
 &nbsp;
 MAT-XU-2203480 (v8.0) 
 Date of preparation: December 2023</td>
 </tr>
 </tbody>
</table>

Website with information for patients prescribed Nexviadyme

Nexviadyme®▼(avalglucosidase alfa) prescribing information GB

Nexviadyme▼ (avalglucosidase alfa) website

<h2>Signs and Symptoms of Gaucher disease</h2>
Gaucher disease has similar signs and symptoms to a number of hematological malignances.

GAUCHER

Downloadable PDF: Signs & Symptoms of Gaucher disease

<h2>To know more about the diagnostic algorithms for Gaucher disease, please click the relevant link below:</h2>

A diagnostic algorithm for adults of Non&ndash;Ashkenazi Jewish origin

A diagnostic algorithm for adults of Ashkenazi Jewish origin

A diagnostic algorithm for adults with splenomegaly and/or thrombocytopenia

A diagnostic algorithm for paediatric patients

Diagnostic Algorithms for Gaucher disease

To read this content, please activate your Sanofi Campus account via the email we've sent to you.

If you didn't receive our first email at {email} to confirm your account you can request a new one below. If you don't see it, you may need to check your spam folder.

title

In order to see relevant content, tell us what you are interested in

Title

Create new password

complete your profile to help us provide you with content that's relevant to you.

Your profile is incomplete

Development of ADCT involved literature review as well as interviews with patients and physicians, and was funded by Sanofi and Regeneron.

The ADCT gives a measure of how controlled your patient’s eczema is. Use these 6 concise questions to evaluate all dimensions of atopic dermatitis control.

Atopic dermatitis, a type of eczema, may be affecting your patient’s life in more ways than you know.

Enjoy more exclusive content{newline}by <a>registering today</a>

MAT-XU-2300297 (v3.0) - Date of preparation: October 2023

MAT-XU-2305062 (v1.0) - Date of preparation: November 2023

MAT-XU-2300297 (v3.0) Date of Preparation: October 2023

MAT-XU-2305047 (v1.0) - Date of preparation: November 2023

Already have an account? <a>Sign in here</a>

Best practices on optimising patient care

Get a customised view of the topics that you're interested in, along with the ability to save content to watch or read at a later date.

Unlimited access to premier content, white papers, case studies, research papers, webinars, training, and up-to-date scientific medical resources.

Personalised content based on your areas of interest

Connect and stay up-to-date with peers in your area of speciality and topics of interest through free events and leadership forums.

Please sign in to continue and read the full article

Please sign up to continue reading the full article.

We respect your privacy and will not share your information with any 3rd parties.

Topical guides written specifically for patients

Unlimited access to the latest patient guide guides and resources. Share content with your patients with easy-to-use online tools.

Please complete your profile to read the content.

Your profile is not validated yet. Please verify your inbox.

Restricted Access

We can't find the page you're looking for

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

You are about to leave Sanofi Campus website.

You are now leaving this site to visit a partner website.

Thank you for visiting COPD Sanofi Campus.

This website is for healthcare professionals only.

Welcome to COPD Sanofi Campus.

Welcome to COPD Sanofi Campus

Please refresh the page to access the content

Sorry, something went wrong

The page you are looking for may be under maintenance, or the link may be incorrect.

Sorry, we can't find this page

You are going to a website that is not operated by Sanofi or a Sanofi website where the terms of use may differ. For external websites, Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party or Sanofi sites.

You are now leaving the Sanofi campus UK website

You are about to leave Campus.sanofi/uk.

Thank you for registering. Before we get started, we need to confirm your email address to ensure that we have the correct information.

Please follow these steps to complete your registration:

Would you like to receive future text messages about Beyfortus updates?

Sanofi is here to help support your patients, their families, and caregivers. For more information regarding Beyfortus®, call <a.callPhoneNumberBeyfortus>1-855-BEYFORTUS (1-855-239-3678)</a.callPhoneNumberBeyfortus> or sign up below to receive the latest updates via email or text. All fields are required.

Would you like to learn more about Beyfortus® (nirsevimab-alip) 50 mg and 100 mg injection? Leave us your contact details, and a Sanofi representative will be in touch.

Do you want to participate in the Beyfortus Reservation Program?

What information are you interested in learning more about? (Optional)

Request a visit from your local ALPROLIX representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local ALTUVIIIO representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local QFITLIA representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your ALPROLIX® Representative or receive updates about ALPROLIX. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your QFITLIA Representative or receive updates about QFITLIA. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

This site is intended for UK healthcare professionals only and contains information on Sanofi UK's medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a UK healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

MAT-XU-2300297 (v6.0) - Date of Preparation: April 2024

Welcome to Sanofi Campus UK

This content is only available to registered users. Please sign in or register to view this content.

Please Sign In

Email verification

You're seeing a preview of the portal. Clear your cookies (by closing your browser window for example) to go back to public mode.

We've updated our privacy notice to better protect your data and enhance your experience. Please take a moment to review the changes by <privacyNewTab>clicking here</privacyNewTab>. Your privary matters for us. Please click on continue to confirm you have read the new privacy notice.

Privacy Notice Update

Communication consent

My Consent

{resultsCount, plural, one {result} other {results}}

Please sign in to access to the results

You need to sign-in to your account in order to access medical content.

To access the results, please register in under 1 minute

You are now leaving the Sanofi content section of our site and entering the external medical bibliographic search content section.

You are entering to the External Scientific Content Site

You are now leaving the external medical bibliographic search section of our site and entering the Sanofi content section.

Latest Resources

Formulary and Service Support

Let’s Be Sustainable

Let’s be Collaborative and Transformative

Hajj & Umrah 2024

Hot Topics in Atopic Dermatitis

Dietician Resources for patients with Rare Diseases

Nexviadyme▼ (avalglucosidase alfa) website

Downloadable PDF: Signs & Symptoms of Gaucher disease

Diagnostic Algorithms for Gaucher disease

Latest Resources

Formulary and Service Support

Let’s Be Sustainable

Let’s be Collaborative​ and Transformative

Hajj & Umrah 2024

Hot Topics in Atopic Dermatitis

Dietician Resources for patients with Rare Diseases

Nexviadyme▼ (avalglucosidase alfa) website

Downloadable PDF: Signs & Symptoms of Gaucher disease

Diagnostic Algorithms for Gaucher disease

Let’s be Collaborative and Transformative